T1	Outcomes 238 250	irritability
T2	Outcomes 703 733	risperidone's safety; efficacy
T3	Outcomes 886 907	insufficient response
T4	Outcomes 917 934	or adverse events
T5	Outcomes 1013 1031	increased appetite
T6	Outcomes 1045 1074	increased weight and vomiting
T7	Outcomes 1085 1148	each); sedation, pyrexia, and upper respiratory tract infection
T8	Outcomes 1159 1181	each); nasopharyngitis
T9	Outcomes 1194 1220	and somnolence and fatigue
T10	Outcomes 1231 1237	each).
T11	Outcomes 1238 1252	Extrapyramidal
T12	Outcomes 1291 1314	Increase in mean weight
T13	Outcomes 1324 1343	and body mass index
T14	Outcomes 1387 1404	because of weight
T15	Outcomes 1419 1476	potentially prolactin-related AE (irregular menstruation)
T16	Outcomes 1545 1585	improvement in sleep visual analog scale
T17	Outcomes 1623 1659	improvement in efficacy scale scores
T18	Outcomes 2004 2053	improvement in irritability and related behaviors
